Article citationsMore>>
Kang, H.J., Lee, H.Y., Na, S.H., Chang, S.A., Park, K.W., Kim, H.K., Kim, S.Y., Chang, H.J., Lee, W., Kang, W.J., Koo, B.K., Kim, Y.J., Lee, D.S., Sohn, D.W., Han, K.S., Oh, B.H., Park, Y.B. and Kim, H.S. (2006) Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC Cell-3-DES randomized, controlled trial
has been cited by the following article:
-
TITLE:
Efficacy and long-term evaluation of intramyocardial injection of autologous CD34-enriched PBMSC in old myocardial infarction
AUTHORS:
José Luis Aceves, Abel Archundia, Araceli Páez, Rafael Vilchis, Elvira Varela, Emma Rodriguez, Guillermo Diaz, Lourdes Flores-Luna, Martha Alvarado, Manuel Lopez H., Luis Felipe Montaño, Felipe Masso
KEYWORDS:
Stem Cells; Myocardial Infarction; CD34+ Cells; Revascularization; Heart Failure; Ventricular Function
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.2 No.4,
October
30,
2012
ABSTRACT: Aims: We have shown that autologous transplant of CD34+-enriched peripheral-blood mononuclear cells (PBMSC) could restore depressed myocardial function, and sustain adequate myocardial function 12 months after surgery in patients with old (>one year-old) myocardial infarction. Our aim is to report the long-term morbidity and mortality efficacy of this procedure. Methods and results: Seventy patients with an old anteroseptal myocardial infarction were followed for 2 to 7 years, 35 had a revascularization procedure and received an intra-myocardial injection of autologous CD34+-enriched PBMSC (8 × 108 mononuclear cells/ml including 3 × 107 CD34+ cells/ml)(Group A). Group B patients only had the revascularization. Abnormal pre-surgical values of LVEF (33.2% ± 4.8%), LVDV (178 ± 13.7 ml), LVSV (120 ± 16 m), LVDD (58.9 ± 3.84 mm), E and A waves without contractility in infarction area in group A patients improved to approximate normal values (50% ± 3% for LVEF; 90 ± 9.3 ml for LVDV; 80 ± 9.9 ml for LVSV; 55.3 ± 3 mm for LVDD; 5.2 ± 0.5 cm/s for E wave and 4.18 ± 0.3 cm/s for A wave) 1 year after the procedure and have remained unaltered for all the follow-up period. All the patients remain alive. Only seven patients have been readmitted to the hospital for non-myocardial related events. Group B only 11 patients continued alive to 5 years after surgery and LEVF never increased more than 6%, all of them with many hospitalizations (n ≥ 10) by heart failure events. Conclusion: Intramyocardial injection of CD34+ highly enriched PBSC represent an encouraging alternative for patients with severely scarred and dysfunctional myocardium.
Related Articles:
-
José Luis Aceves, Rafael Vilchis, María Antonieta Medina, Monserrat Borja, Silvia Cortes, Guillermo Díaz, Armando Castro, Alexis Gómez, José J. Parra, Martha Alvarado, Manuel López Hernández, Virna Poveda, Felipe Masso, Luis F. Montaño
-
Kasra Azarnoush, Mario Manca, Andrea Innorta, Lionel Camilleri
-
Knox Kwon
-
Bréhima Coulibaly, Abdoulaye Kanté, Mamadou A Keita, Mamadou Diakité, Bakary Keita, Drissa Traoré, Nouhoum Ongoïba, Patrice Binuani, Christophe Baufreton
-
Negar Salehi, Rahimeh Eskandarian, Hamid Reza Sanati, Ata Firouzi, Farshad Shakerian, Seyfollah Abdi, Homan Bakhshandeh, Mojde Nasiri Ahmad Abadi, Negin Nouri, Anoushiravan Vakili-Zarch